Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease

Journal of the Neurological Sciences

Volumn 104, Issue 2, 1991, Pages 203-208

  Bindoff, L A ^a   Birch Machin, M A ^a   Cartlidge, N E F ^a   Parker Jr , W D ^b   Turnbull, D M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Mitochondria; Parkinson's disease; Respiratory chain; Skeletal muscle

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MALE; MITOCHONDRION; MUSCLE BIOPSY; PARKINSON DISEASE; PRIORITY JOURNAL; RESPIRATORY CHAIN;

ADULT; BLOTTING, WESTERN; CASE REPORT; CYTOCHROMES; HUMAN; MALE; MIDDLE AGE; MITOCHONDRIA, MUSCLE; MULTIENZYME COMPLEXES; NAD(P)H DEHYDROGENASE (QUINONE); OXIDOREDUCTASES; OXYGEN CONSUMPTION; PARKINSON DISEASE; REFERENCE VALUES; SUCCINATE DEHYDROGENASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; UBIQUINOL-CYTOCHROME-C REDUCTASE;

EID: 0025831821     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(91)90311-T     Document Type: Article

References (44)

1. Mammalian succinate dehydrogenase
2. Ultrastructure of skeletal muscle in patients with Parkinson's disease and upper motor lesions
3. Parkinson's disease: clinical features and etiopathology
4. New data on the genetics of Parkinson's Disease
5. Ecogenetic of Parkinson's disease: 4-hydroxylation of debrisoquine
6. Mitochondrial function in Parkinson's Disease
7. Fatal lactic acidosis in infancy with a defect of complex III of the respiratory chain
8. Aetiology of Parkinson's disease
9. Metabolism of the neurotoxic tertiary amine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by brain monoamine oxidase
10. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde
11. Expression of the mammalian mitochondrial genome, stability of the mitochondrial translation products as a function of membrane potential
12. Chronic parkinsonism secondary to intravenous injection of meperidine analogues
13. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
14. +) cause rapid ATP depletion in isolated hepatocytes
15. Quantitation of Rabbit cytochrome P-450, form 2, in microsomal preparations bound directly to nitrocellulose paper using a modified peroxidase-immunostaining technique
16. Genetics of Parkinson's Disease
17. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
18. Skeletal muscle
19. Studies on the electron transfer pathway, topography of iron-sulphur centers and site of coupling in NADH-Q oxidoreductase
20. Epidemiology: incidence, geographic distribution and genetic considerations
21. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4
22. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
23. Presence of tetrahydro-isoquinoline and 1-methyl-tetrahydroisoquinoline in foods: compounds related to foods
24. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
25. Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease
26. An endogenous substance in the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions
27. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
28. Electron transport chain abnormalities in idiopathic Parkinson's disease
29. A simplification of the protein assay method of Lowry et al. which is more generally applicable
30. Cohort analysis of Parkinson's syndrome evidence for a single etiology related to sub clinical infection about 1920
31. Energy dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria
32. Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism
33. Cyanide-induced Parkinsonism: Clinical, MRI and 6-flurodopa PET studies
34. Mitochondrial complex I deficiency in Parkinson's disease
35. Citrate synthase from rat liver
36. MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease
37. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline
38. 1
39. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications
40. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing
41. Tetracyano-2,2-bipyridineiron (III), an improved electron acceptor for the spectrophotometric assay of β-oxidation and of succinate dehydrogenase in intact mitochondria
42. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
43. 14C]hexadecanoate oxidation
44. Effect of temperature on the spectral properiies of some ferrocytochromes